Read the full story on the faculty news feed and see also JAMA invited commentary by Joe Verghese.
Showing posts with label ASPREE. Show all posts
Showing posts with label ASPREE. Show all posts
2 Jun 2022
Slowing of gait and cognitive decline together is a predictor of dementia
A landmark study of more than 16,800 older people has found that a decline in both walking speed and cognition is a strong predictor of future dementia. The authors of the study, published in the prestigious Journal of the American Medical Association (JAMA) Open, suggest simple memory and walking speed testing, done in health clinics, may allow early preventive measures to be put in place to prevent the individual and global cost of diseases such as Alzheimer’s.
17 Dec 2015
Slowing down age-related hearing loss
By Dr Jodie Abramovitch
Loss of hearing associated with age is a leading
cause of disability amongst older people. Low level
inflammation may damage blood vessels within the ear, leading to hearing loss.
Furthermore, hearing loss may be associated with blood vessel damage
within the eye, as well as loss of cognitive function. This suggests that there
may be a common underlying inflammatory cause for each of these age-related conditions.
![]() |
| Can aspirin reduce age-related hearing loss? |
Aspirin is a commonly used anti-inflammatory medication. It
has a known role in helping treat blood vessel diseases and can inhibit the formation
of blood clots.
Monash researchers from the School of Public Health and Preventive Medicine (SPHPM) are involved in a new study called ASPREE-HEARING.
This study will assess the effect of aspirin on hearing levels in
patients aged 70 years and older who are involved in the ASPirin in Reducing Events in the
Elderly (ASPREE) clinical trial.
Subscribe to:
Posts (Atom)

